Our Company was established in 1957 by top leading pharmacists in order to supply excipients, APIs and specialty chemicals to Turkish Pharma Industry. From the beginning, the company has been adopted to high-quality service generating solutions to customers and suppliers as a leader of sustainable relations.
Marmara Ecza is an official distributor of Evonik, Meggle, Blanver, Omya, IGH Flavours in Turkey and also, strategic supplier of Ashland, Roquette, Budenheim, Konya Þeker. Moreover, Marmara Ecza is supplying almost every raw materials which are used in pharmaceutical, cosmetic, OTC and veterinary medicine industries via their own certified warehouses in compliance with GDP standarts and logistics.
Contact
Marmara Ecza ve Kimyevi Maddeler Sanayi ve Ticaret A.S.
Ikitelli OSB Suleyman Demirel Bulvari Ziya Gokalp Mah. Sinpas Is Modern F Blok No:37 Basaksehir Istanbul
T: +90 (212) 520 54 35/36
F: +90 (212) 526 26 25
email: marmaraecza@marmaraecza.com.tr
Web: marmaraecza.com.tr
Tugce Gozacan (pictured) and Okan Gozacan, Owner and Chairman of Marmara Ecza respectively, discuss what qualities are crucial for suppliers in the pharmaceutical industry, their process for forming partnerships and…
Ismail Yormaz, vice president & regional director south-east at Recordati, shares the management secrets that have helped him grow Recordati into one of the top pharma companies in Turkey. He…
Sule Mene, co-founder, president and CEO of Mene Health Group, shares with PharmaBoardroom the journey of her company starting as the first government-approved CRO of Turkey, its parallel growth alongside…
Tuğçe Koç reveals how Onko Koçsel was able to quickly grow from an in-licenser to a production-oriented pharmaceutical company with an international reach. She also offers her take on how…
Kazim Dinç, chairman of the board of SURDER and former Minister of Health of Turkey, offers his insights into the Turkish OTC and health products market, highlighting the challenges facing…
Despite the sharp decline in the Turkish lira’s value, the general mood among pharmaceutical executives in Turkey is positive. Rather than being discouraged, they are calling upon their resiliency and…
Acibadem’s Mehmet Ali Aydınlar offers his insights into the Turkish healthcare sector, highlighting Turkey’s burgeoning healthcare tourism industry. He also describes Acıbadem’s focus of growth, globalization and fundamental values that…
Murat Kavrar, country manager at Ekol Turkey, offers readers a look at Ekol’s innovative approach to the logistics sector, emphasizing his company’s R&D capacity and eco-friendly solutions that provide client…
With the construction of state-of-the-art public and private hospitals, Turkey is poised to become a global leader in medical tourism. Turkey has always been a popular tourist destination, given…
Abidin Gulmus, founder and chairman of Gen Ilaç, describes the company’s impressive journey to become Turkey’s principle orphan drug distributor and shares his vision for leveraging the company’s domestic expertise…
In 2016 the Turkish Medicine and Medical Devices Agency (TiTCK) implemented a localisation policy to reduce Turkey’s reliance on imports – a few years later, it has created a young,…
Massimo d’Eufemia, head representative of the European Investment Bank (EIB) in Turkey, highlights the importance of Turkey for the EIB and how the country’s geographic position and key economic role…
Tahsin Yüksel, general manager of Teva Turkey, analyzes the strategic importance of pharmaceutical branding in Turkey, shares the story of Teva’s adaptation to the unique market needs, and offers his…
See our Cookie Privacy Policy Here
